Drug Pricing Déjà Vu: The Biden-Harris Administration's Fiscal Year 2024 Budget Doubles Down on Inflation Reduction Act Reforms; CMMI and MedPAC Also Weigh In
As outlined in our prior analysis, the Inflation Reduction Act (IRA) included…
Stay updated with breaking news from Negotiation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As outlined in our prior analysis, the Inflation Reduction Act (IRA) included…
Are Accelerated Approval Drugs a New Target for Cost Reductions? As outlined in our prior analysis, the Inflation Reduction Act (IRA) included sweeping drug pricing reforms for the...
The Inflation Reduction Act of 2022 (IRA), signed into law last August, seeks to overhaul the way Medicare buys and pays for prescription drugs. A regulatory undertaking of this scope is certain to generate...
The Inflation Reduction Act of 2022 (IRA), signed into law last August, seeks to overhaul the way Medicare buys and pays for prescription drugs. A regulatory undertaking of this scope...
The Inflation Reduction Act of 2022 (IRA) establishes the Medicare Drug Price Negotiation Program ("Negotiation Program"), which permits the government to negotiate drug prices for certain high expenditure, single source Medicare Part B and Part D drugs.